Subcutaneous Magnesium Sulfate to Correct High-Output Ileostomy-Induced Hypomagnesemia

Abstract

Fluid and magnesium abnormalities are common in patients with high-output stomas. Subcutaneous magnesium administration may be more feasible for long-term management in ambulatory patients, but magnesium sulfate is approved only for intravenous or intramuscular injection. We describe the management of chronic hypomagnesemia and dehydration secondary to a high-output ileostomy following radiation and chemotherapy for anal squamous cell carcinoma with intermittent home-based subcutaneous magnesium infusions in a 61-year-old female with a history of Crohn’s disease and multiple bowel resections. Despite aggressive management with intravenous magnesium sulfate and oral magnesium glucoheptonate over 8 months, 49% of her magnesium concentrations were <0.60 mmol/L (mean 0.61 ± 0.09) necessitating 4 emergency, 1 hospital, and 4 infusion clinic visits. After initiation of subcutaneous magnesium sulfate, all magnesium concentrations were >0.60 mmol/L (mean 0.79 ± 0.08 mmol/L over 9 months). The patient tolerated the infusions well, only developing one minor episode of infusion-related cellulitis. A systematic review of the literature identified 14 reports where subcutaneous magnesium sulfatewas effective and treatment for adults or children with hypomagnesemia was safe. Home-based intermittent administration of subcutaneous magnesium may be a helpful and safe intervention to temporarily prevent and treat select patients with recurrent symptomatic hypomagnesemia.

Off-label drug use in palliative care – a narrative review

“…diuretyków). Podawanie siar czanu magnezu dożylnie, a nawet podskórnie jest dosyć dobrze tolerowane oraz zapewnia skuteczną suplementację u chorych na przykład z nadmierną utratą elektrolitów w przebiegu objawowych zespo łów krótkiego jelita [40].…”

Use of oral rehydration solution and intravenous fluid in home settings for adults with short bowel syndrome

“…Areas such as the safety of at-home infusion of intravenous bicarbonate solutions or other individual micronutrients should be prioritized to research feasible interventions as the market has demanded over the past decade. Therapies that warrant a closer look at this time also include the delivery of electrolytes via subcutaneous injection or infusion in the home setting, which may prove useful for patients with SBS with specific electrolyte needs, refractory to oral supplementation 40. SUMMARYDehydration due to SBS is a complex and challenging condition that needs careful monitoring and appropriate treatments.…”